1 Year Total Returns (Daily) Chart

View 1 Year Total Returns (Daily) for HUMA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View 1 Year Total Returns (Daily) Chart
Start Trial

Historical 1 Year Total Returns (Daily) Data

View and export this data back to 2021. Start Trial.
Date Value
September 15, 2026 -63.95%
September 14, 2026 -61.84%
September 11, 2026 -62.16%
September 10, 2026 -61.68%
September 09, 2026 -61.40%
September 08, 2026 -57.81%
September 04, 2026 -58.57%
September 03, 2026 -59.18%
September 02, 2026 -60.49%
September 01, 2026 -63.20%
August 31, 2026 -61.20%
August 28, 2026 -58.85%
August 27, 2026 -54.73%
August 26, 2026 -53.63%
August 25, 2026 -53.25%
August 24, 2026 -58.09%
August 21, 2026 -58.30%
August 20, 2026 -58.20%
August 19, 2026 -53.92%
August 18, 2026 -67.68%
August 17, 2026 -70.18%
August 14, 2026 -67.83%
August 13, 2026 -69.10%
August 12, 2026 -62.95%
August 11, 2026 -59.31%
Date Value
August 10, 2026 -69.98%
August 07, 2026 -70.92%
August 06, 2026 -67.89%
August 05, 2026 -68.45%
August 04, 2026 -68.49%
August 03, 2026 -69.77%
July 31, 2026 -72.78%
July 30, 2026 -72.36%
July 29, 2026 -73.65%
July 28, 2026 -74.47%
July 27, 2026 -73.36%
July 24, 2026 -76.60%
July 23, 2026 -76.61%
July 22, 2026 -71.97%
July 21, 2026 -70.83%
July 20, 2026 -71.84%
July 17, 2026 -72.53%
July 16, 2026 -72.40%
July 15, 2026 -70.11%
July 14, 2026 -71.37%
July 13, 2026 -70.08%
July 10, 2026 -72.36%
July 09, 2026 -72.43%
July 08, 2026 -71.47%
July 07, 2026 -64.31%

Total Return Definition

The Total return is the change in price over a specific period of time that includes dividends and distributions paid.

Read full definition.

1 Year Total Returns (Daily) Range, Past 5 Years

View 1 Year Total Returns (Daily) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

1 Year Total Returns (Daily) Benchmarks

View 1 Year Total Returns (Daily) Benchmarks
Start Trial
Amgen, Inc. 40.68%
Altimmune, Inc. -10.03%
Protalix Biotherapeutics, Inc. 39.27%
Taysha Gene Therapies, Inc. 67.55%
Agenus, Inc. 60.90%